On May 28, 2025, Precision BioSciences held its annual stockholders meeting where two directors were elected and several proposals, including the appointment of Deloitte as auditors, were approved; however, a proposed amendment regarding officer exculpation failed to pass as it lacked majority support from outstanding shares.